[REQ_ERR: 404] [KTrafficClient] Something is wrong. Enable debug mode to see the reason.
Antiretroviral therapy and communities of color
May 28, · Request PDF | Antiretroviral Therapy and Communities of Color | The current HIV treatment guidelines from both the DHHS and IAS indicate that the best choices for first . AIDS-related mortality–19 The The cohort was predominantly composed of people of color. dictors of nonadherence to antiretroviral therapy (ART) and. Some studies have demonstrated that blacks (and in . Apr 21, Several studies have examined the effect of race on treatment outcome with mixed results. However, African Americans, compared with Caucasians or Hispanics, were less likely to receive HAART (adjusted. A large study of ten HIV primary care centers from across the USA analyzed the association between use of antiretroviral therapy in and a variety of demographic and clinical characteristics of 10, individuals The study found that previously identified factors such as age more than 40 years and male gender were associated with greater use of HAART by multivariate analysis. 54, 55 Repeatedly, these examinations have found that nonwhite or African American race is a risk factor for virologic failure in univariate a. Investigators at the Johns Hopkins University HIV Clinic have examined risk factors for virologic failure in a large urban clinic at several time points in the era of highly active antiretroviral therapy. The current HIV treatment guidelines from both the DHHS and IAS indicate that the best choices for first-line therapy include either efavirenz (EFV) or a ritonavir-boosted protease . Sept Thus, while use and adherence to antiretroviral medications has been a under participation of people of color) can be successful, Brief.